Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis. J of Skin [Internet]. 2024 Jan. 16 [cited 2026 May 25];8(1):s320. Available from: https://skin.dermsquared.com/skin/article/view/2401